EPO Patents = 4

Forward Citations = 0

Loading Chart...

8 inventors (with patents filed for the assignee):

Heeyong Lee (4 out of 4 patents)

Eunyoung Seol (4 out of 4 patents)

Yongha Na (3 out of 3 patents)

4. Kwonhyeok Yoon (2 out of 2 patents)

5. Juhan Lee (2 out of 3 patents)

6. Dongpil Won (1 out of 1 patent)

7. Yejin Kim (1 out of 1 patent)

8. Heekyoung Choe (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 12605426 - Pharmaceutical comprising sustained-release microspheres including GLP-1 analogue or pharmaceutically acceptable salt thereof (2026-04-21),

2. 12274787 - Sustained-release injection comprising deslorelin, and preparation method therefor (2025-04-14),

3. 11590258 - Vitamin C-containing polycaprolactone microsphere filler and preparation method therefor (2023-02-28),

4. 11311854 - Method for preparing biodegradable microspheres having improved stability and storage stability (2022-04-26),

Company Overview

G2gbio, Inc. is a biotechnology company focused on developing innovative solutions for genomic research and personalized medicine. They specialize in high-throughput genomic sequencing and bioinformatics services that enable researchers to unlock the potential of genomic data. G2gbio aims to facilitate advancements in genomics by providing state-of-the-art technologies and expertise to academic, clinical, and industrial partners. Their mission is to empower scientists in their pursuit of discoveries that can lead to breakthroughs in disease treatment and health management.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#122 in Daejeon

#2,200 in South Korea

Daejeon, South Korea

G2gbio, Inc.

Forward Citations = 0

8 inventors:

Heeyong Lee (4 out of 4 patents)

Eunyoung Seol (4 out of 4 patents)

Yongha Na (3 out of 3 patents)

4. Kwonhyeok Yoon (2 out of 2 patents)

5. Juhan Lee (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: G2gbio, Inc.. Retrieved from https://idiyas.com/company/g2gbio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]